Updates on the CABANA and AMAZE Trials: What Is the Efficacy of Catheter Ablation vs. Antiarrhythmic Drug Therapy Among Patients With Atrial Fibrillation? Does the Left Atrial Appendage Occluder Help in the Management of Permanent A-Fib?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Updates on the CABANA and AMAZE Trials: What Is the Efficacy of Catheter Ablation vs. Antiarrhythmic Drug Therapy Among Patients With Atrial Fibrillation? Does the Left Atrial Appendage Occluder Help in the Management of Permanent A-Fib?

By The Texas Heart Institute FEATURING Mehdi Razavi

935 views

April 20, 2021

0 Comments

LAA Closure for Atrial Fibrillation using Occlusion Device

Feat. H. Sievert

13:54

Stanford Medicine

How I Manage Patients with Frequent PVCs

Feat. R. John

18:36

The Texas Heart Institute

Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?

Feat. M. Razavi

22:57

The France Foundation

Insights into Advances in Nonvalvular Atrial Fibrillation: Exploring…

Feat. C. Ruff, J. Walker

Boston Scientific

Proven to Reduce NVAF Stroke Risk for Life

Boston Scientific

Designed to Protect a Broad Range of Patients

Boston Scientific

Patient Eligibility Criteria

Boston Scientific

Clinically Proven to Safely & Effectively Reduce NVAF Stroke Risk

Boston Scientific

Advancing Safety & Simplicity in LAAC - See the Difference

Boston Scientific

Clinically Proven Safe Outcomes - PINNACLE FLX Clinical Trial Data

Boston Scientific

Most Studied & Implanted LAAC Device

Boston Scientific

Proven Safety & Advanced Procedural Performance

11:34

Cardiopulmonary Research Science and Technology Institute

The Mouse on the Yellow Umbrella: Mechanisms of Atrial Fibrillation

Feat. J. Cox

08:15

Georgia Heart Institute

Interview with Dr. Christopher Ellis: Left Atrial Appendage Manageme…

Feat. D. Weisman, C. Ellis

Boston Scientific

Advancing Safety In LAAC

18:26

Stanford Medicine

When Is LAA Closure Device an Option?

Feat. C. Liu

91:14

Virtual EP Connect

Postural Tachycardia Syndrome: Pathophysiology and Impact of Tragus …

Feat. V. Reddy, F. Marchlinski, T. Glotzer, B. Olshansky, S. Po, S. Stavrakis

06:37

Mayo Clinic Proceedings

Antiarrhythmic Drugs for AF in the Outpatient Setting

Feat. C. Desimone

14:16

Penn Medicine Heart and Vascular Center

Stroke Prevention in Atrial Fibrillation

Feat. D. Goldberg

34:24

The France Foundation

Insights into Advances in Nonvalvular Atrial Fibrillation: Creating …

Feat. C. Ruff

Login

Login

Join VuMedi

Updates on the CABANA and AMAZE Trials: What Is the Efficacy of Catheter Ablation vs. Antiarrhythmic Drug Therapy Among Patients With Atrial Fibrillation? Does the Left Atrial Appendage Occluder Help in the Management of Permanent A-Fib?

Related Content